<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:  Purification of Metallic Nitride Nanomaterials by Chemical Separation</AwardTitle>
<AwardEffectiveDate>01/01/2004</AwardEffectiveDate>
<AwardExpirationDate>12/31/2006</AwardExpirationDate>
<AwardAmount>724884</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>William Haines</SignBlockName>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research (SBIR) Phase II project will involve production and purification of a powerful Magnetic Resonance Imaging (MRI) contrast agent based on a newly discovered nanomaterial (Trimetasphere), consisting of a metallic nitride nanocluster inside a fullerene type cage.  Trimetaspheres recently demonstrated a factor of 21 times improved relaxivity over currently used MRI contrast agents.  The project will involve designing and building a powder-feed continuous reactor, including large rod capability, developing chemically-based separations techniques and optimizing heat treatment of the chemically separated Trimetaspherses mixtures.  The nanoproduction and chemical-based separations techniques for these Trimetasphere nanomaterials will provide the basis for the large-scale production of the Trimetasphere based MRI contrast agents.&lt;br/&gt;&lt;br/&gt;Commercially, these Trimetaspheres have tremendous medical applications that will benefit US citizens with better medical care through improved diagnostics, new pharmaceuticals, and simultaneous diagnostic and treatment reagents, at a fraction of current cost.  The development of more sensitive contrast agents, if translated into smaller, less expensive MRI instruments, will open entirely new markets for the equipment manufacturers.</AbstractNarration>
<MinAmdLetterDate>12/12/2003</MinAmdLetterDate>
<MaxAmdLetterDate>10/25/2004</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0349691</AwardID>
<Investigator>
<FirstName>Steven</FirstName>
<LastName>Stevenson</LastName>
<EmailAddress>stevenss@pfw.edu</EmailAddress>
<StartDate>12/12/2003</StartDate>
<EndDate>08/04/2004</EndDate>
<RoleCode>Former Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Stephen</FirstName>
<LastName>Wilson</LastName>
<EmailAddress>keena@lunainnovations.com</EmailAddress>
<StartDate>08/04/2004</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Luna Innovations, Incorporated</Name>
<CityName>Roanoke</CityName>
<ZipCode>240111921</ZipCode>
<PhoneNumber>5407698400</PhoneNumber>
<StreetAddress>301 1st Street SW</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Virginia</StateName>
<StateCode>VA</StateCode>
</Institution>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>5373</Code>
<Text>SMALL BUSINESS PHASE II</Text>
</ProgramElement>
<ProgramReference>
<Code>1788</Code>
<Text>Nanomanufacturing</Text>
</ProgramReference>
<ProgramReference>
<Code>9163</Code>
<Text>SINGLE DIVISION/UNIVERSITY - INDUSTRY</Text>
</ProgramReference>
<ProgramReference>
<Code>AMPP</Code>
<Text>ADVANCED MATERIALS &amp; PROCESSING PROGRAM</Text>
</ProgramReference>
</Award>
</rootTag>
